Inhalation CDMO Market Size, Growth & Competitive Outlook 2024-2033
The inhalation cdmo global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Inhalation CDMO Market, 2024 report by The Business Research Company offers
comprehensive insights into the current state of the market and highlights
future growth opportunities.
Market Size -
The inhalation CDMO market size has grown strongly in recent years. It will
grow from $1.94 billion in 2023 to $2.08 billion in 2024 at a compound annual
growth rate (CAGR) of 7.1%. The growth
in the historic period can be attributed to rising prevalence of respiratory
disorders, growing demand for personalized medicine, increasing outsourcing by
pharmaceutical companies, growth of the biopharmaceutical industry.
The inhalation CDMO market size is expected to see strong growth in the next
few years. It will grow to $2.7 billion in 2028 at a compound annual growth
rate (CAGR) of 6.8%. The growth in the
forecast period can be attributed to focus on precision medicine and targeted
therapies, rapid expansion of biopharmaceutical inhalation therapies,focus on
patient-centric solutions, global market expansion and emerging market
opportunities, regulatory support for inhalation drug development. Major trends
in the forecast period include increasing demand for digital health solutions,
biologic inhalation therapies, focus on sustainable inhaler technologies,
integration of artificial intelligence (AI) and machine learning,
collaborations and partnerships.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/inhalation-cdmo-global-market-report
Scope Of Inhalation CDMO Market
The Business Research Company's reports encompass a wide range of information,
including:
1. Market Size (Historic and Forecast): Analysis of the market's historical
performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market
landscape.
4. Key Segments: Breakdown of the market into its primary segments and their
respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and
geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting
the market.
Inhalation CDMO Market Overview
Market Drivers -
The increasing prevalence of respiratory disorders is expected to propel the
growth of the inhalation CDMO market going forward. Respiratory disorders are a
group of medical conditions that affect the respiratory system, which includes
the organs and structures involved in breathing. Inhalation CDMOs are used in
the development and manufacturing of products for respiratory disorders due to
their expertise in formulating and delivering drugs to the lungs, offering
specialized expertise, infrastructure, and resources to pharmaceutical
companies seeking to bring innovative inhalation therapies. For instance, in
June 2023, according to reports shared by the Australian Institute of Health
and Welfare, an Australia-based national agency, there was a rise in
respiratory disease-related deaths from 43,031 in 2020 to 46,551 in 2021in
Australia. Furthermore, in September 2022, according to the data published by
The Lancet, a UK-based book and periodic data publishing organization, 11,255
new cases of RSV were recorded in 2021, which is 11.4% more compared to 9,972
cases in 2020. Therefore, the increasing prevalence of respiratory disorders is
driving the growth of the inhalation CDMO market.
Market Trends -
Major companies operating in the inhalation CDMO industry are adopting a
strategic partnership approach to provide specialized drug development and
delivery. A strategic partnership is a long-term, mutually beneficial
arrangement between two or more companies that work together to achieve shared
goals. For instance, in May 2023, Hovione, a Portugal-based Contract
Development and Manufacturing Organization, partnered with H&T Presspart, a
UK-based manufacturer of high-precision metal and plastic components for the
pharmaceutical industry, to develop Presspart's Sunrise Capsule-based Dry
Powder Inhaler platform. This partnership focuses on developing new
technologies that can deliver higher doses of drugs and improve the efficiency
of drug delivery to the lungs.
The inhalation cdmo market covered in this report is segmented –
1) By Product: Dry Powder Inhaler (DPIs), Metered Dose Inhaler (MDIs),
Nebulizer, Soft Mist Inhaler
2) By Disease Indication: Asthma, Chronic Obstructive Pulmonary Disease (COPD),
Pulmonary Arterial Hypertension, Acute Respiratory Distress Syndrome, Pulmonary
Fibrosis
3) By Technology: Manual Inhalers (SMI), Digital Inhalers
4) By End-User: Big Pharmaceutical Companies, Small and Medium-sized
Pharmaceutical Companies, Generic Pharmaceutical Companies, Other End-Users
Get an inside scoop of the inhalation cdmo market, Request now for Sample
Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=13864&type=smp
Regional Insights -
North America was the largest region in the inhalation contract development and
manufacturing organization (CDMO) market in 2023. The regions covered in the
inhalation cdmo market report are Asia-Pacific, Western Europe, Eastern Europe,
North America, South America, Middle East, Africa.
Key Companies -
Pfizer Inc., Merck KGaA, Baxter’s BioPharma Solutions, Lonza Group AG, Catalent
Inc., AptarGroup Inc., Samsung Biologics Co. Ltd., Siegfried Holding AG,
Recipharm AB, Stevanato Group SpA, Cambrex Corporation, CordenPharma, Nemera,
Hovione FarmaCiencia SA, Vectura Group Ltd., CARBOGEN AMCIS, Kindeva Drug
Delivery Ltd., Frontage Laboratories Inc, Formosa Laboratories Inc, Sanner
GmbH, H&T Presspart Ltd., Astech Projects Ltd, Cliantha Research, Dipharma
Francis Srl, Copley Scientific
Table of Contents
1. Executive Summary
2. Inhalation CDMO Market Report Structure
3. Inhalation CDMO Market Trends And Strategies
4. Inhalation CDMO Market – Macro Economic Scenario
5. Inhalation CDMO Market Size And Growth
…..
27. Inhalation CDMO Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model:
https://www.thebusinessresearchcompany.com/global-market-model
Comments
Post a Comment